Fig. 4: Differential immune gene expression signatures and correlations in Luminal B breast cancer surgical samples post neoadjuvant treatment. | npj Breast Cancer

Fig. 4: Differential immune gene expression signatures and correlations in Luminal B breast cancer surgical samples post neoadjuvant treatment.

From: Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy

Fig. 4

a Expression of selected signature in surgical samples with complete cycle arrest (CCCA) and non-CCCA in ribociclib arm (left) and chemotherapy arm (right). b Spearman correlation matrix for continuous PAM50 proliferation score and cibersort immune population in surgical samples after neoadjuvant ribociclib and letrozole. c Spearman correlation matrix for continuous PAM50 proliferation score and cibersort immune population in surgical samples after neoadjuvant multi-agent chemotherapy.

Back to article page